Characterizing Risk Factors Associated With Recurrent Pleural Effusions in the Lung Transplant Recipients.

IF 3.3 Q2 RESPIRATORY SYSTEM
Ilana Roberts Krumm, Katherine Malcolm, Maya Vella, Aris Oates, Steve Hays, Jasleen Kukreja, Yaron B Gesthalter
{"title":"Characterizing Risk Factors Associated With Recurrent Pleural Effusions in the Lung Transplant Recipients.","authors":"Ilana Roberts Krumm, Katherine Malcolm, Maya Vella, Aris Oates, Steve Hays, Jasleen Kukreja, Yaron B Gesthalter","doi":"10.1097/LBR.0000000000000992","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pleural effusions remain a common postoperative complication following lung transplantation, occurring in 10% to 26% of cases. We aimed to explore potential clinical or radiographic features associated with clinically significant post-lung transplant pleural effusions requiring repeat interventions for their management.</p><p><strong>Methods: </strong>Lung transplantation recipients who underwent thoracentesis at our institution between June 2012 and October 2022 were reviewed. In total, 77 patients were included. Data were collected via the electronic health record and adjudicated through direct chart review. Patients were stratified by the need for a single thoracentesis (control group) or additional interventions, including serial thoracentesis, pigtail placement, and surgery (composite group). The computed tomography (CT) of the chest before the first thoracentesis was reviewed by a thoracic radiologist who was blinded to patient outcome.</p><p><strong>Results: </strong>Single thoracentesis was used to manage 25 (32.5%) patients, 4 (5.2%) required multiple thoracenteses, 42 (54.5%) required a pigtail catheter, and 6 (7.8%) required decortication for definitive management. In the composite group compared with the control group, who were managed by a single thoracentesis, there was an increased incidence of loculations (36.8% vs. 8%, P=0.01), rounded atelectasis (22.8% vs. 4%, P=0.05), and larger effusion size (P=0.01). The composite group had higher pleural fluid eosinophils (0.33% vs. 0% in control, P = <0.01) and monocytes (14.8% vs. 7.3%, P=0.04) levels.</p><p><strong>Conclusion: </strong>Baseline imaging, such as larger effusion size, loculations and rounded atelectasis, and pleural fluid cell profile with increased eosinophils and monocytes, can potentially identify clinically significant and refractory pleural effusions.</p>","PeriodicalId":15268,"journal":{"name":"Journal of Bronchology & Interventional Pulmonology","volume":"32 1","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bronchology & Interventional Pulmonology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/LBR.0000000000000992","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Pleural effusions remain a common postoperative complication following lung transplantation, occurring in 10% to 26% of cases. We aimed to explore potential clinical or radiographic features associated with clinically significant post-lung transplant pleural effusions requiring repeat interventions for their management.

Methods: Lung transplantation recipients who underwent thoracentesis at our institution between June 2012 and October 2022 were reviewed. In total, 77 patients were included. Data were collected via the electronic health record and adjudicated through direct chart review. Patients were stratified by the need for a single thoracentesis (control group) or additional interventions, including serial thoracentesis, pigtail placement, and surgery (composite group). The computed tomography (CT) of the chest before the first thoracentesis was reviewed by a thoracic radiologist who was blinded to patient outcome.

Results: Single thoracentesis was used to manage 25 (32.5%) patients, 4 (5.2%) required multiple thoracenteses, 42 (54.5%) required a pigtail catheter, and 6 (7.8%) required decortication for definitive management. In the composite group compared with the control group, who were managed by a single thoracentesis, there was an increased incidence of loculations (36.8% vs. 8%, P=0.01), rounded atelectasis (22.8% vs. 4%, P=0.05), and larger effusion size (P=0.01). The composite group had higher pleural fluid eosinophils (0.33% vs. 0% in control, P = <0.01) and monocytes (14.8% vs. 7.3%, P=0.04) levels.

Conclusion: Baseline imaging, such as larger effusion size, loculations and rounded atelectasis, and pleural fluid cell profile with increased eosinophils and monocytes, can potentially identify clinically significant and refractory pleural effusions.

分析肺移植受者胸腔积液复发的相关风险因素
背景:胸腔积液仍是肺移植术后常见的并发症,发生率为 10%-26%。我们旨在探究与肺移植术后胸腔积液相关的潜在临床或影像学特征,这些胸腔积液具有显著的临床意义,需要重复介入治疗:我们对 2012 年 6 月至 2022 年 10 月期间在我院接受胸腔穿刺术的肺移植受者进行了回顾性研究。共纳入 77 例患者。数据通过电子病历收集,并通过直接审阅病历进行判定。根据患者是否需要进行单次胸腔穿刺术(对照组)或额外干预(包括连续胸腔穿刺术、辫子置入术和手术)(复合组)进行分层。首次胸腔穿刺术前的胸部计算机断层扫描(CT)由一名胸腔放射科医生进行复查,该医生对患者的治疗结果保密:结果:25 名(32.5%)患者采用了单次胸腔穿刺术,4 名(5.2%)患者需要多次胸腔穿刺术,42 名(54.5%)患者需要使用辫子导管,6 名(7.8%)患者需要去骨瓣手术进行最终治疗。与采用单次胸腔穿刺术的对照组相比,复合组的定位率(36.8% 对 8%,P=0.01)、圆形无气胸(22.8% 对 4%,P=0.05)和积液面积增大(P=0.01)的发生率均有所增加。综合组的胸腔积液嗜酸性粒细胞更高(0.33% 对对照组的 0%,P=0.01):基线成像,如较大的渗出液体积、定位和圆形无气腔,以及胸腔积液细胞特征(嗜酸性粒细胞和单核细胞增多),可潜在地识别临床上重要的难治性胸腔积液。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.40
自引率
6.10%
发文量
121
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信